In June 2016, EFSA received a mandate from the national food competent authorities of five European countries (Denmark, Finland, Iceland, Norway and Sweden) to provide a dietary reference value (DRV) for sugars, with particular attention to added sugars. ...
In 2016, the European Food Safety Authority (EFSA) received a mandate from the European Commission to update its 2009 opinion on the appropriate age for introduction of complementary feeding of infants. In order to retrieve data on health outcomes related ...
On 19 September 2012, Séralini et al. published online in the scientific journal Food and Chemical Toxicology a publication describing a 2-year feeding study in rats investigating the health effects of genetically modified maize NK603 with and without Rou ...
On 19 September 2012, Séralini et al. published online in the scientific journal Food and Chemical Toxicology a publication describing a 2-year feeding study in rats investigating the health effects of genetically modified (GM) maize NK603 with and withou ...
The European Food Safety Authority (EFSA) received in December 2011, a request from the European Commission for an update on the possible scientific developments for cloning of farmed animals for food production purposes. The present Statement follows the ...
The European Food Safety Authority was requested to perform a comparison between the doses of several neonicotinoids tested in the studies from Henry et al. (honeybees, thiamethoxam) and Whitehorn et al., (bumblebees, imidacloprid) published in Science (2 ...
The European Food Safety Authority (EFSA) received in May 2010, a request from the European Commission for an update on the state of play of the possible scientific developments on the issue of cloning of farmed animals for food production purposes. The p ...
No abstract available doi: 10.2903/j.efsa.2009.319r Question Number: EFSA-Q-2009-00449 Adopted: 23 June 2009 Last Updated: 24 November 2009 Type: Statement of EFSA ...
No abstract available Keywords: Bisphenol A, CAS no. 80-05-7, cardiovascular disease, diabetes, liver-enzyme abnormalities doi: 10.2903/j.efsa.2008.838 Question Number: EFSA-Q-2008-702 Adopted: 22 October 2008 Type: Statement of EFSA ...